Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatiti...
Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis
About this item
Full title
Author / Creator
Briggs, Emily , Kamal, Mohamed A. , Kosloski, Matthew P. , Linsmeier, Ian , Jusko, Natalie , Dolphin, Nancy , Chittenden, Jason , Simpson, Eric L. , Paller, Amy S. , Siegfried, Elaine C. , Shumel, Brad , Levit, Noah A. , Bansal, Ashish , Davis, John D. , Chapel, Sunny , Smith, David E. and Huniti, Nidal
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Background
While the majority of patients with atopic dermatitis (AD) achieve disease control with dupilumab treatment, there is variability in which patients achieve clear disease. The predictors of these responses are currently unclear. Integrated models were developed to evaluate the exposure–response (E-R) relationship of dupilumab in childr...
Alternative Titles
Full title
Integrated Exposure–Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10733507
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10733507
Other Identifiers
ISSN
0724-8741
E-ISSN
1573-904X
DOI
10.1007/s11095-023-03616-8
